Evidence map›Paper›PMID 38752003›Full record

ReviewClinical and experimental vaccine research2024

Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis.

Faranak Salajegheh, Mohammad Rezaei Zadeh Rukerd, Mohsen Nakhaie, Zohreh-Al-Sadat Ghoreshi, Javad Charostad, Nasir Arefinia

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical and experimental vaccine research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Faranak SalajeghehClinical Research Development Unit, School of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0003-4368-779X
Mohammad Rezaei Zadeh RukerdGastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0001-8390-4344
Mohsen NakhaieGastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0001-7605-2593
Zohreh-Al-Sadat GhoreshiSchool of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.ORCID https://orcid.org/0000-0002-0556-3000
Javad CharostadDepartment of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran.ORCID https://orcid.org/0000-0001-8434-2523
Nasir ArefiniaSchool of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.ORCID https://orcid.org/0000-0002-7282-3538

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of coronavirus disease 2019 (COVID-19) vaccines has been a remarkable advancement. However, the efficacy, immunogenicity, and safety of these vaccines in individuals with liver cirrhosis require careful evaluation due to their compromised immune status and potential interactions with underlying liver disease. The present study aimed to evaluate the safety and efficacy of COVID-19 vaccines in liver cirrhosis patients. In the present study, we searched international databases, including Google Scholar, PubMed, Scopus, Embase, and Web of Science. The search strategy was carried out by using keywords and MeSH (Medical Subject Headings) terms. STATA ver. 15.0 (Stata Corp., USA) was used to analyze the data statistically. The analysis was performed using the random-effects model. We also used the chi-square test and I

Indexed as

COVID-19 vaccineEfficacyImmunogenicityLiver cirrhosisSafety

Identifiers

PMID38752003
PMCPMC11091435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.